Australia has already spent hundreds of millions over the past 36 months after raising the prices of 950 PBS medicines in 2022 to secure supply in a challenging global environment. If global pressure now forces higher prices for other medicines, so be it, but of course, it would be just another stop-gap solution for a system built on a terrible patient-loathing law.
Australia can increase prices in response to pressure, as it did just 36 months ago for 950 medicines
December 2, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
The private market might do what two decades of PBS reform attempts couldn't
October 12, 2026 - - Latest News -
The full set of numbers tell the story and reveal the massive funding shortfall
October 12, 2026 - - Latest News -
Private prescription market heads towards $4 billion as PBS spending stalls
October 12, 2026 - - Latest News -
The 'Dispatched' Podcast Week in Review - Series 5. Ep.35
October 9, 2026 - - Podcast -
PhRMA goes to court over price rule that uses Australia as a benchmark
October 9, 2026 - - Latest News -
A tale of two systems with billions shifting to the private market
October 9, 2026 - - Latest News -
GLP-1s are quickly reshaping the Australian prescription medicines market
October 9, 2026 - - Latest News
